Tomoki Masuda

Induction of <i>WT1</i> (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression

Akihiro Tsuboi, Tetsuya Taguchi, Tadashi Osaki et al. · Proceedings of the National Academy of Sciences · 2004 · 526 citations · Full text

Medicine, Immunology, Oncology +17

The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia

Hiroyasu Ogawa, Hiroya Tamaki, Kazuhiro Ikegame et al. · Blood · 2003 · 225 citations · Full text

Life Sciences, Genetics, Oncology +13

Wilms tumor gene peptide-based immunotherapy for patients with overt Leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis

Akihiro Tsuboi, Masaki Murakami, Manabu Hirai et al. · International Journal of Hematology · 2003 · 123 citations

Medicine, Immunology, Oncology +16

Unmanipulated HLA 2–3 Antigen-Mismatched (Haploidentical) Stem Cell Transplantation Using Nonmyeloablative Conditioning

Hiroyasu Ogawa, Kazuhiro Ikegame, Satoshi Yoshihara et al. · Biology of Blood and Marrow Transplantation · 2006 · 121 citations · Full text

Medicine, Hematology, Immunology +17

Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues

Akihiro Tsuboi, Keiko Udaka, Masaki Murakami et al. · Cancer Immunology Immunotherapy · 2002 · 118 citations · Full text

Life Sciences, Immunology, Molecular Biology +15